Blog

LAS VEGAS, NEVADA / ACCESS Newswire / May 27, 2025 / Avant Technologies Inc. (OTCQB:AVAI) (“Avant” or the “Company”), and its JV partner, Ainnova Tech, Inc., (Ainnova), a leading healthcare technology company focused on revolutionizing early disease detection using artificial intelligence (AI), today announced the companies are exploring options to integrate the early detection of dementia into Ainnova’s proprietary, AI-powered platform technology, Vision AI. The addition would reinforce the Company’s mission of expanding AI-powered early detection and preventative health solutions across the globe.

Currently, the Company has identified a promising patented early disease detection technology specializing in the early detection of dementia and is exploring its options to either license the technology globally or potentially acquire the technology altogether. The patented technology combines AI algorithms and hardware based on a 5-minute blood test. Adding the early detection of dementia would expand the offerings in the Company’s technology portfolio and enhance the broader vision of the partnership between Avant and Ainnova.

The success of the Company’s preventative screening platform involves the deployment of an automated, low-cost retinal imaging device integrated with the Vision AI platform to deliver comprehensive preventive risk screening. Presently, from just two retinal images, blood pressure and some lab test information, the Company’s system uses 4 integrated algorithms to assess risks for: (i) cardiovascular disease (CVD), (ii) type 2 diabetes, (iii) liver fibrosis, and (iv) chronic kidney disease (CKD).

Vinicio Vargas, Chief Executive Officer at Ainnova and member of the Board of Directors of the joint venture company, Ai-nova Acquisition Corp., said of the potential expansion of its technology portfolio, “This accessible, fast, and scalable solution is designed to support early intervention and targeted treatment strategies, with the ambition of reaching millions of patients globally in the coming years. Adding the early detection of dementia that this patented technology presents us, would go a long way to making us a leader in the industry of early disease detection.”

About Ainnova Tech, Inc.

Ainnova is a Nevada-based healthtech startup with headquarters in San Jose, Costa Rica, and Houston, Texas. Founded by an experienced and innovative team that is dedicated to leveraging artificial intelligence for early disease detection. Recognized with multiple global awards and renowned partnerships with hospitals and medical device companies, we proudly introduce Vision AI – our cutting-edge platform designed to prevent blindness and detect the early onset of diabetes. Explore how Ainnova is revolutionizing healthcare through advanced technology and proactive solutions.

About Avant Technologies Inc.

Avant Technologies Inc. is an emerging technology company developing solutions in artificial intelligence in healthcare. With a focus on pushing the boundaries of what is possible in AI and machine learning, Avant serves a diverse range of industries, driving progress and efficiency through state-of-the-art technology.

More information about Avant can be found at https://avanttechnologies.com

You can also follow us on social media at:

https://twitter.com/AvantTechAI
https://www.linkedin.com/company/avant-technologies-ai
https://www.facebook.com/AvantTechAI
https://www.youtube.com/@AvantTechAI

Forward-Looking Statements

Certain statements contained in this press release may constitute “forward-looking statements.” Forward-looking statements provide current expectations of future events based on certain assumptions and include any statement that does not directly relate to any historical or current fact. Actual results may differ materially from those indicated by such forward-looking statements because of various important factors as disclosed in our filings with the Securities and Exchange Commission located at their website (http://www.sec.gov). In addition to these factors, actual future performance, outcomes, and results may differ materially because of more general factors including (without limitation) general industry and market conditions and growth rates, economic conditions, governmental and public policy changes, the Company’s ability to raise capital on acceptable terms, if at all, the Company’s successful development of its products and the integration into its existing products and the commercial acceptance of the Company’s products. The forward-looking statements included in this press release represent the Company’s views as of the date of this press release and these views could change. However, while the Company may elect to update these forward-looking statements at some point in the future, the Company specifically disclaims any obligation to do so. These forward-looking statements should not be relied upon as representing the Company’s views as of any date after the date of the press release.

Contact:

Avant Technologies Inc.
info@avanttechnologies.com

SOURCE: Avant Technologies Inc.

View the original press release on ACCESS Newswire

CAMBRIDGE, MA / ACCESS Newswire / May 27, 2025 / Moderna, Inc. (Nasdaq:MRNA), today announced its participation in the following upcoming investor conferences:

Jefferies Global Health Care Conference, on Thursday, June 5^th at 10:30am ET

Goldman Sachs 46^th Annual Global Healthcare Conference, on Wednesday, June 11^th at 8:40am ET

A live webcast of each of these presentations will be available under “Events and Presentations” in the Investors section of the Moderna website.

investors.modernatx.com.

A replay of each webcast will be archived on Moderna’s website for at least 30 days following the presentation.

About Moderna

Moderna is a leader in the creation of the field of mRNA medicine. Through the advancement of mRNA technology, Moderna is reimagining how medicines are made and transforming how we treat and prevent disease for everyone. By working at the intersection of science, technology and health for more than a decade, the company has developed medicines at unprecedented speed and efficiency, including one of the earliest and most effective COVID-19 vaccines.

Moderna’s mRNA platform has enabled the development of therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases and autoimmune diseases. With a unique culture and a global team driven by the Moderna values and mindsets to responsibly change the future of human health, Moderna strives to deliver the greatest possible impact to people through mRNA medicines. For more information about Moderna, please visit modernatx.com and connect with us on X (formerly Twitter), Facebook, Instagram, YouTube and LinkedIn.

Investors:
Lavina Talukdar
Senior Vice President & Head of Investor Relations
617-209-5834
Lavina.Talukdar@modernatx.com

SOURCE: Moderna, Inc.

View the original press release on ACCESS Newswire

LOS ANGELES, CA / ACCESS Newswire / May 26, 2025 / Historical romance has long been a refuge for those seeking escapism-a world of grand ballrooms, whispered confessions, and neatly tied happy endings. Arabella Pascal’s Zanzibar (2nd Edition) shatters these conventions with the force of a hurricane. This is not a novel that merely entertains; it confronts, challenges, and unsettles. Set against the opulent backdrop of Victorian England and the brutal reality of East Africa’s slave trade, Zanzibar forces readers to grapple with romance’s most uncomfortable question: Can love truly flourish where power is violently unequal? Pascal’s answer is as breathtaking as it is devastating-a story where passion and oppression collide, leaving no heart unscathed.

The Architect: Arabella Pascal (née Jerri Levi)

Arabella Pascal is no ordinary romance novelist. An art historian by training, she penned Zanzibar while living in Africa, embedding her prose with the precision of an academic and the fire of a storyteller. Comparisons to Diana Gabaldon are inevitable-both authors wield history like a blade-but Pascal’s work cuts deeper, exposing the psychological scars of colonization with unflinching clarity. Her protagonist, Charlotte Earnshaw, is no simpering debutante but a woman ensnared-first by Zanzibar’s enigmatic Prince Jasim Bin Rashid, then by the gilded cages of her own family’s secrets.

What sets Pascal apart is her refusal to simplify. Jasim, the so-called villain, is the only character who truly sees Charlotte’s humanity, blurring the line between captor and liberator. Meanwhile, her bonus content, “What Charlotte Wore,” dissects 19th-century fashion with the rigor of a scholar, drawing parallels between the constriction of corsets and the suffocation of colonial rule. This is historical romance as reclamation-a genre often dismissed as frivolous transformed into a vessel for reckoning.

The Real-World Impact: Romance as Reckoning

Pascal’s novel doesn’t just subvert romance tropes; it ignites them like gunpowder. The classic “captive falls for captor” dynamic becomes a moral quagmire, forcing readers to question where desire ends and complicity begins. Even the villainous brother-in-law, Derek, is a mirror for patriarchy’s banality-a reminder that oppression often wears a familiar face. Fans of Sandra Brown’s taut suspense will find Gabaldon’s depth here, but with a twist: Zanzibar demands engagement, not just escapism.

The numbers prove its resonance. Dark romance is surging in popularity, but Zanzibar stands apart-62% of Goodreads reviewers call it “unlike anything they’ve read,” a testament to its unflinching blend of passion and politics. Its recognition as a finalist for the Best Long Historical by the Romance Writers of America underscores its duality: a love story that refuses to look away from history’s darkest corners. Even the audiobook, narrated by British actor Gary Appleton, has captured 40% of sales, a nod to Pascal’s commitment to authenticity.

The Future: Can Romance Novels Be Radical?

Pascal’s next project, a thriller set in the Belgian Congo, signals her unwavering mission: to drag romance into the arena of cultural critique. She’s part of a bold new wave of authors challenging the genre to confront its blind spots. Can a “happily ever after” exist when the wounds of history are still raw? Should love stories sidestep oppression for the sake of escapism? These are the questions Zanzibar forces into the light, proving that romance can be both swoon-worthy and revolutionary.

Conclusion: The Heart in Chains

Zanzibar is more than a novel-it’s an indictment. Arabella Pascal wields romance like a scalpel, dissecting the illusions of power and desire with surgical precision. In her hands, the genre becomes a rebellion, petticoats and all. The darkest chains, she reminds us, aren’t the ones around the wrists-they’re the ones around the heart.

PR Toolkit for Evrima Chicago

The press hook writes itself: “The Romance Novel That’s Too Dangerous for Bridgerton Fans.” Target film blogs with its cinematic potential (Outlander meets 12 Years a Slave), pitch academic journals on its revisionist take on history, and let Pascal’s own words seal the deal: “Writing Zanzibar felt like solving a puzzle-one where the pieces were stained with blood and rosewater.”

Purchase links and media contacts stand ready. The only question left is: Are readers prepared for a love story that refuses to let them look away?

Purchase Links : Amazon

Disclaimer – Evrima Chicago
This original article was independently researched and published by the Evrima Chicago News Bureau and has not been previously published in any form before today. It is intended for editorial use and syndication on the world wide web as part of our coverage on contemporary literary works and their cultural relevance.

Not Endorsed by the Author
The views and interpretations expressed herein are those of our editorial team and are not sponsored, commissioned, or officially endorsed by Jerri Levi (Arabella Pascal).

Publication Standards
This piece qualifies as a digital-first publication under recognized W3C web content syndication frameworks and is timestamped for archival and distribution purposes.

No Liability for Obsessive Readers
Evrima Chicago disclaims all liability for readers who finish Zanzibar and immediately book flights to Stonehenge or Zanzibar. Historical obsession may occur.

Publisher Note
Evrima Chicago is an independent media and research outlet producing editorial content across literature, history, modern culture, AI, accessibility (A11Y), and news media.

© 2025 Evrima Chicago. All rights reserved.

SOURCE: Evrima Chicago

View the original press release on ACCESS Newswire

Clear Start Tax Shows How Americans Are Transforming Tax Burdens Into Fresh Starts

IRVINE, CA / ACCESS Newswire / May 26, 2025 / For thousands of Americans grappling with back taxes, the IRS Fresh Start Program has opened the door to meaningful relief – but many taxpayers still don’t realize they qualify. Clear Start Tax, a national leader in tax resolution, helps clients turn overwhelming tax problems into manageable solutions.

A Game-Changer for Taxpayers Struggling With Tax Debt

Launched to help struggling taxpayers regain stability, the Fresh Start Program offers more than just payment plans – it offers a chance to reduce tax balances, avoid aggressive collections, and reclaim financial peace of mind. Whether through an Offer in Compromise that settles debt for a fraction of what’s owed, a tailored Installment Agreement, or Currently Not Collectible status that halts IRS actions during hardship, these tools have reshaped the financial future of thousands.

“Many taxpayers are surprised to learn the IRS offers legitimate relief options,” said the Head of Client Solutions at Clear Start Tax. “Our focus is on helping clients access these solutions and regain financial stability with confidence.”

Why Proactive Action Pays Off

Clear Start Tax emphasizes that early action can make all the difference. Waiting too long can trigger wage garnishments, bank levies, or liens that shrink options and escalate costs. Acting early allows taxpayers to preserve access to the most flexible solutions – and can even unlock better settlement terms.

How the Fresh Start Program Works

The IRS Fresh Start Program was designed to help taxpayers resolve back taxes in a manageable, structured way. It works by assessing the taxpayer’s current financial situation – including income, expenses, assets, and liabilities – to determine what level of repayment is realistic. Depending on eligibility, the IRS may agree to reduce the total amount owed, set up a payment plan, or pause collections entirely. To qualify, taxpayers must stay current on future tax filings and submit detailed financial information to demonstrate their hardship or limited ability to pay.

The Clear Start Tax Difference: Strategy, Advocacy, Results

What sets Clear Start Tax apart isn’t just its knowledge of IRS programs – it’s the firm’s hands-on, client-first approach. Each case starts with a detailed financial assessment, allowing the team to match the client to the right program. From there, Clear Start Tax handles complex paperwork, negotiates directly with IRS agents, and stays by the client’s side through every step of the process.

“Our role isn’t just to fill out forms – it’s to be a strategist, an advocate, and a guide,” added the Head of Client Solutions. “We help people regain control of their finances, not just their ledgers.”

About Clear Start Tax

Clear Start Tax is a full-service tax liability resolution firm that serves taxpayers throughout the United States. The company specializes in assisting individuals and businesses with a wide range of IRS and state tax issues, including back taxes, wage garnishment relief, IRS appeals, and offers in compromise. Clear Start Tax helps taxpayers apply for the IRS Fresh Start Program, providing expert guidance in tax resolution. Fully accredited and A+ rated by the Better Business Bureau, the firm’s unique approach and commitment to long-term client success distinguish it as a leader in the tax resolution industry.

Need Help With Back Taxes?

Click the link below:
https://clearstarttax.com/qualifytoday/

Contact Information

Clear Start Tax
Corporate Communications Department
seo@clearstarttax.com
(949) 535-1627

SOURCE: Clear Start Tax

View the original press release on ACCESS Newswire

VIENNA, AUSTRIA / ACCESS Newswire / May 26, 2025 / involve.me, a leading no-code platform for creating conversion-focused funnels, has announced the launch of its latest innovation: the AI-generated Text feature. This new addition empowers marketing & sales teams from SMBs to deliver real-time, personalized content within their funnels, increasing user engagement and conversion rates.

The AI-Generated Text feature allows users to generate personalized text, in real-time, based on individual responses within a funnel. To do so, involve.me users simply input prompts into the feature, and the AI rapidly produces relevant content, such as messages, recommendations, and summaries, tailored specifically to the user’s inputs.

“Our AI-generated Text feature removes some of the traditional bottlenecks associated with static websites” stated Vlad Gozman, CEO at involve.me. “We understand how critical personalization is for lead conversion, and with this AI innovation, we empower businesses to offer content that resonates deeply with their target audiences, providing instant personalized value and driving more conversions.“

Key Features and Benefits:

• Real-Time Personalization: Generate unique content instantly as users interact with your funnel.

• Answer Piping: Incorporate user responses directly into the prompts for context-aware outputs.

• Enhanced Lead Magnets: Generate personalized B2C and B2B lead magnets that provide individual value in real-time

• No coding required: Easily add the AI-Generated Text element to any part of your funnel using the drag-and-drop editor.

With this new feature, involve.me continues its commitment to innovation and user-centric design, reinforcing its position as a leading platform for AI funnel creation and lead generation. “We’re set on staying at the forefront by leveraging the latest advances in AI to democratize funnel creation and help businesses grow.” said Vlad Gozman.

About involve.me

involve.me is a dynamic lead funnel creation platform that empowers businesses to turn website visitors into qualified leads through interactive, conversion-optimized funnels.

The platform features an intuitive no-code builder, allowing users to create multi-step funnels using elements like forms, quizzes, calculators, and surveys. With advanced features such as conditional logic, answer piping, and custom outcomes, involve.me customizes each user journey to deliver a more personalized and engaging experience that drives higher conversions, all while automatically qualifying leads in the background.

Projects, from product finders to appointment forms, can be launched quickly, whether starting from scratch, customizing one of 300+ templates, or leveraging the AI funnel generator for instant, branded funnels.

Suitable for businesses across industries and sizes, involve.me supports full brand personalization, mobile responsiveness, and integration with 65+ platforms including Salesforce, HubSpot, Mailchimp, and Zapier. Real-time analytics and AI-generated reports help users fine-tune performance and maximize results.

For more information about the AI-Generated Text feature, visit https://www.involve.me/features/ai-generated-text

Media Contact:
Jonathan Davies
Content Marketer
involve.me
jonathan@involve.me
+43 676 54 53 047

SOURCE: involve.me

View the original press release on ACCESS Newswire

Video Recording & Voting Results

VANCOUVER, BC / ACCESS Newswire / May 26, 2025 / Nano One® Materials Corp. (“Nano One” or the “Company”) (TSX:NANO)(OTC PINK:NNOMF)(Frankfurt:LBMB), a process technology company specializing in lithium-ion battery cathode active materials provides a summary of the results from the Annual General Meeting.

To watch a video recording of the 2025 Annual General Meeting presentation and access the accompanying corporate materials, please visit:
https://nanoone.ca/investors/agm/

Results of Annual General Meeting

Nano One is pleased to announce the results of the annual general meeting of shareholders (the “Meeting”). All matters presented for shareholder approval at the Meeting were approved, as follows:

1. Election of the Directors of the Company for the ensuing year;

2. Appointment of Davidson & Company LLP as Auditors of the Company for the ensuing year and authorizing the directors to fix their remuneration;

A total of 35,878,667 common shares were represented by proxy and in person at the Meeting, representing 32.18% of the total issued and outstanding common shares of the Company, which represents quorum.

Election of Directors

The five nominees listed in the Company’s management information circular dated April 14, 2025, were elected Directors as set out below:

Nominee	Outcome of Vote	Votes For	% For	Votes Withheld	% Withheld
Anthony Tse	Carried	35,737,253	99.61%	141,414	0.39%
Dan Blondal	Carried	35,862,953	99.96%	15,714	0.04%
Dr. Joseph Guy	Carried	35,730,591	99.59%	148,076	0.41%
Carla Matheson	Carried	35,758,203	99.66%	120,464	0.34%
Lisa Skakun	Carried	35,758,543	99.67%	120,124	0.33%

Appointment of Independent Auditor

Resolution	Outcome of Vote	Votes For	% For	Votes Withheld	% Withheld
Appointment of Davidson & Company LLP as Auditors of the Corporation for the ensuing year and authorizing the Directors to fix their remuneration.	Carried	35,865,367	99.96%	13,330	0.04%

Detailed voting results for each of the matters voted on at the meeting will be available for viewing on our website and on SEDAR+ at www.sedarplus.ca.

Nano One’s Board of Directors and Executive Team extend their gratitude to Lyle Brown and Gord Kukec for their service as Board members over the years. The Company appreciates their support, counsel, and contributions, and wishes them well in their future endeavours.

###

About Nano One®

Nano One® Materials Corp. (Nano One) is a technology company changing how the world makes cathode active materials for lithium-ion batteries. Applications include stationary energy storage systems (ESS), portable electronics, and electric vehicles (EVs). The Company’s patented One-Pot process reduces costs, is easier-to permit, lowers energy intensity, environmental footprint, and reliance on problematic supply chains. The Company is helping to drive energy security, supply chain resilience, industrial competitiveness and increased performance through process innovation. Scalability is proven and being demonstrated at Nano One’s LFP (lithium-iron-phosphate) pilot production plant in Québec-leveraging the only facility and expertise of its kind outside of Asia. Strategic collaborations and partnerships with international companies like Sumitomo Metal Mining, Rio Tinto, and Worley are supporting a design-one-build-many licensing growth strategy-delivering cost-competitive, easier-to-permit and faster-to-market battery materials production solutions world-wide. Nano One has received funding from the Government of Canada, the Government of the United States, the Government of Québec, and the Government of British Columbia. For more information, please visit www.nanoone.ca

Company Contact:

Paul Guedes
info@nanoone.ca
(604) 420-2041

Cautionary Notes and Forward-looking Statements

Certain information contained herein may constitute “forward-looking information” and “forward-looking statements” within the meaning of applicable securities legislation. All statements, other than statements of historical fact, are forward-looking statements. Forward-looking information in this news release includes but is not limited to: LFP production, joint ventures, contracted projects, revenue generation, operational growth, licensing, government funding, the development of technology, supply chains, and plans for construction and operation of cathode production facilities and Development Project; the Company’s current and future business and strategies; estimated future working capital, funds available, and uses of funds, future capital expenditures and other expenses for commercial operations; industry demand; incurrence of costs; competitive conditions; general economic conditions; the intention to grow the business, operations and potential activities of the Company; the functions and intended benefits of Nano One’s technology and products; the development and optimization of the Company’s technology and products; prospective partnerships and the anticipated benefits of the Company’s partnerships; the Company’s licensing and, the scalability of developed technology to meet expanded capacity; and the execution of the Company’s stated plans – which are contingent on access to capital and grants. Generally, forward-looking information can be identified by the use of terminology such as ‘believe’, ‘expect’, ‘anticipate’, ‘plan’, ‘intend’, ‘continue’, ‘estimate’, ‘may’, ‘will’, ‘should’, ‘ongoing’, ‘target’, ‘goal’, ‘potential’ or variations of such words and phrases or statements that certain actions, events or results “will” occur.

Forward-looking statements are based on the current opinions and estimates of management as of the date such statements are made are not, and cannot be, a guarantee of future results or events. Forward-looking statements are subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of the Company to be materially different from those expressed or implied by such forward-looking statements or forward-looking information, including but not limited to: general and global economic and regulatory changes; next steps and timely execution of the Company’s business plans; the development of technology, supply chains, and plans for construction and operation of cathode production facilities; successful current or future collaborations that may happen with OEM’s, miners or others; the execution of the Company’s plans which are contingent on capital sources; the Company’s ability to achieve its stated goals; the commercialization of the Company’s technology and patents via license, joint venture and independent production; anticipated global demand and projected growth for LFP batteries; and other risk factors as identified in Nano One’s MD&A and its Annual Information Form dated March 25, 2025, both for the year ended December 31, 2024, and in recent securities filings for the Company which are available at www.sedarplus.ca. Although management of the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking statements or forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements and forward-looking information. The Company does not undertake any obligation to update any forward-looking statements or forward-looking information that is incorporated by reference herein, except as required by applicable securities laws.

SOURCE: Nano One Materials Corp.

View the original press release on ACCESS Newswire

As Australians seek to reduce gas and electricity usage, Liberty says personal loans could help make efficient-home upgrades a possibility.

MELBOURNE, AUSTRALIA / ACCESS Newswire / May 25, 2025 / The Australian Government committed $1.8 billion to extending the Energy Relief Fund in the 2025-26 Federal Budget – an initiative providing rebates on household energy bills until December 2025.

While this support is welcome, particularly during the colder months, many may be seeking long-term strategies to improve the efficiency and comfort of their homes.

From replacing outdated appliances to installing double-glazed windows and new insulation, improving a home’s energy performance often involves a combination of upgrades. However, the upfront costs are a barrier for many.

Non-bank lender Liberty offers personal loans as a practical way to manage the upfront expenses involved with these upgrade projects, allowing homeowners to spread the cost of materials and labour over time.

According to Communications Manager Bernadine Pantarotto, personal loans support Australians in achieving their goals while staying on top of their budget.

“Making your home more energy efficient could deliver many benefits, from year-round comfort to potential long-term savings,” Ms Pantarotto said.

“Liberty personal loans are designed with flexibility in mind, helping you bring your plans to life sooner.”

Liberty says consumers could also use a personal loan for other purposes, including for travel, wedding planning, medical expenses, and debt consolidation.

With loan amounts of up to $80,000 and an easy online application process, Liberty offers a fast and convenient way for customers to access the finance they need. In some cases, approved applicants may even receive funds on the same day.

“As free thinkers, we champion inclusive lending practises to help everyone access the support they need.”

Liberty takes a holistic approach to credit assessment, considering a range of customer circumstances – including those with variable income and less-than-perfect credit histories.

“We believe people are more than their circumstances and find innovative ways to support them,” Ms Pantarotto said.

Along with personal loans, the leading lender offers flexible home, car, business, commercial and SMSF loans.

About Liberty
As one of Australia’s leading non-bank lenders, Liberty offers innovative solutions to support customers with greater choice. Over more than 27 years, this free-thinking approach to loan solutions has seen more than 900,000 customers across a wide range of home, car, business and personal loans, as well as SMSF lending and insurance. Liberty remains the only non-bank lender with an investment-grade credit rating offering custom and prime solutions to help more people get financial.

Approved applicants only. Lending criteria apply. Fees and charges are payable. Liberty Financial Pty Ltd ACN 077 248 983 and Secure Funding Pty Ltd ABN 25 081 982 872 Australian Credit Licence 388133, together trading as Liberty Financial.

Contact
Laura Orchard
Media Coordinator
P: +61 3 8635 8888
E: mediaenquiries@liberty.com.au

SOURCE: Liberty

View the original press release on ACCESS Newswire

As Australian business owners plan for the new financial year, Liberty business loans provide support to those looking to stay ahead of the curve.

MELBOURNE, AUSTRALIA / ACCESS Newswire / May 25, 2025 / The Australian Bureau of Statistics reported business turnover rose by 0.5% in trend terms in March, led by the wholesale trade sector. Despite global uncertainty and weather-related disruptions, monthly turnover has been steadily increasing since September 2024.

As Australian businesses put plans in place to remain ahead of the curve in the new financial year, Liberty highlights the importance of timely funding.

Communications Manager, Bernadine Pantarotto, says Liberty remains ready to support businesses to capitalise on this momentum and fuel their next phase of growth.

“In a dynamic economic environment, access to timely and flexible funding is critical for businesses looking to innovate, expand, or simply stay ahead of the curve,” Ms Pantarotto says.

“Whether it’s funding for expansion, equipment upgrades, or working capital, Liberty works closely with business owners to find the right fit.”

With over two decades of experience, Liberty is a leading lender that supports businesses of all sizes.

The innovative non-bank offers a suite of flexible loans to suit a variety of business needs, including low doc business loans, secured business loans and business lines of credit.

These options provide the flexibility business owners need to act quickly and confidently.

“Fast and flexible business loans can help business owners say ‘yes’ to growth opportunities,” adds Ms Pantarotto.

Growth looks different for every business, and Liberty understands that a one-size-fits-all approach to finance isn’t the answer.

As a free-thinking lender, Liberty takes a holistic view of each borrower’s financial situation. This tailored approach allows Liberty to offer flexible lending solutions that align with each business’s unique goals, challenges, and opportunities.

“Whether it’s a new small business or a large, established operation, Liberty is ready help those customers that others may not take the time to understand,” says Ms Pantarotto.

For about 30 years now, Liberty has provided innovative lending solutions that help individuals, investors, business owners, and beyond, move towards their goals.

Beyond business loans, Liberty also offers free-thinking home, car, personal, commercial, and SMSF loans.

About Liberty
As one of Australia’s leading non-bank lenders, Liberty offers innovative solutions to support customers with greater choice. Over more than 27 years, this free-thinking approach to loan solutions has seen more than 900,000 customers across a wide range of home, car, business and personal loans, as well as SMSF lending and insurance. Liberty remains the only non-bank lender with an investment-grade credit rating offering custom and prime solutions to help more people get financial.

Approved applicants only. Lending criteria apply. Fees and charges are payable. Liberty Financial Pty Ltd ACN 077 248 983 and Secure Funding Pty Ltd ABN 25 081 982 872 Australian Credit Licence 388133, together trading as Liberty Financial.

Contact
Laura Orchard
Media Coordinator
P: +61 3 8635 8888
E: mediaenquiries@liberty.com.au

SOURCE: Liberty

View the original press release on ACCESS Newswire

CAMBRIDGE, MA / ACCESS Newswire / May 23, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that it has submitted an application to the U.S. Food and Drug Administration (FDA) for review of its Spikevax 2025-2026 formula, targeting the SARS-CoV-2 variant LP.8.1. The submission is based on guidance from the U.S. FDA, which advised that COVID-19 vaccines should be updated to a monovalent JN.1 lineage, with a preference for the LP.8.1 variant.

About Moderna

Moderna is a leader in the creation of the field of mRNA medicine. Through the advancement of mRNA technology, Moderna is reimagining how medicines are made and transforming how we treat and prevent disease for everyone. By working at the intersection of science, technology and health for more than a decade, the company has developed medicines at unprecedented speed and efficiency, including one of the earliest and most effective COVID-19 vaccines.


Moderna’s mRNA platform has enabled the development of therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases and autoimmune diseases. With a unique culture and a global team driven by the Moderna values and mindsets to responsibly change the future of human health, Moderna strives to deliver the greatest possible impact to people through mRNA medicines. For more information about Moderna, please visit modernatx.com and connect with us on X (formerly Twitter), Facebook, Instagram, YouTube and LinkedIn.

AUTHORIZED USE IN THE U.S.

INDICATION (U.S.)

SPIKEVAX (COVID-19 Vaccine, mRNA) is a vaccine indicated for active immunization to prevent coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in individuals 12 years of age and older.

IMPORTANT SAFETY INFORMATION

Contraindications

• Do not administer SPIKEVAX to individuals with a known history of severe allergic reaction (e.g., anaphylaxis) to any component of SPIKEVAX.

Warnings and Precautions

• Management of Acute Allergic Reactions: Appropriate medical treatment to manage immediate allergic reactions must be immediately available in the event an acute anaphylactic reaction occurs following administration of SPIKEVAX.

• Myocarditis and Pericarditis: Post marketing data demonstrate increased risks of myocarditis and pericarditis, particularly within the first week following vaccination. The observed risk is highest in males 18 years through 24 years of age.

• Syncope (fainting): May occur in association with administration of injectable vaccines, including SPIKEVAX. Procedures should be in place to avoid injury from fainting.

• Altered Immunocompetence: Immunocompromised persons, including individuals receiving immunosuppressive therapy, may have a diminished response to SPIKEVAX.

• Limitations of Vaccine Effectiveness: SPIKEVAX may not protect all vaccine recipients.

Adverse Reactions

The most commonly reported (≥10%) adverse reactions following any dose in any indicated patient population were pain at the injection site, headache, fatigue, myalgia, chills, arthralgia, axillary swelling/tenderness, nausea/vomiting, swelling at the injection site, erythema at the injection site, and fever.

Reporting Adverse Events and Vaccine Administration Errors

The vaccination provider is responsible for mandatory reporting of certain adverse events to the Vaccine Adverse Event Reporting System (VAERS) online at https://vaers.hhs.gov/reportevent.html or by calling 1-800-822-7967.

Please see the SPIKEVAX Full Prescribing Information.

Please see the Moderna COVID-19 Vaccine Fact Sheet for Healthcare Providers Administering Vaccine for more information.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, as amended, including statements regarding: Moderna’s regulatory submission to the U.S. FDA for its Spikevax 2025-2026 formula, including the potential for approval in the U.S. The forward-looking statements in this press release are neither promises nor guarantees, and you should not place undue reliance on these forward-looking statements because they involve known and unknown risks, uncertainties, and other factors, many of which are beyond Moderna’s control and which could cause actual results to differ materially from those expressed or implied by these forward-looking statements. These risks, uncertainties, and other factors include, among others, those risks and uncertainties described under the heading “Risk Factors” in Moderna’s Annual Report on Form 10-K for the fiscal year ended December 31, 2024, and in subsequent filings made by Moderna with the U.S. Securities and Exchange Commission, which are available on the SEC’s website at www.sec.gov. Except as required by law, Moderna disclaims any intention or responsibility for updating or revising any forward-looking statements contained in this press release in the event of new information, future developments or otherwise. These forward-looking statements are based on Moderna’s current expectations and speak only as of the date of this press release.

Moderna Contacts

Media:
Chris Ridley
Global Head of Media Relations
+1 617-800-3651
Chris.Ridley@modernatx.com

Investors:
Lavina Talukdar
Senior Vice President & Head of Investor Relations
+1 617-209-5834
Lavina.Talukdar@modernatx.com

SOURCE: Moderna, Inc.

View the original press release on ACCESS Newswire

Debut Features MUSQ ETF With Long-Form Interviews, National TV Commercials, and Iconic Billboard Exposure

NEW YORK, NY / ACCESS Newswire / May 23, 2025 / New to The Street, the award-winning financial media platform known for elevating growth companies and funds through strategic storytelling and nationwide visibility, proudly announces the launch of its newest flagship segment, ETF Leaders: Opportunities To Consider™. The inaugural feature showcases MUSQ, the first exchange-traded fund tracking the global music industry ecosystem.

The series will air across Bloomberg Television and Fox Business Network (as sponsored programming), complemented by a comprehensive multi-platform rollout including long-form interviews, TV commercials, and Times Square billboard exposure-uniquely positioned to drive ETF discovery and visibility.

“We’re thrilled to launch ETF Leaders with MUSQ, a fund that perfectly captures the spirit of innovation we aim to highlight,” said Vincent Caruso, CEO and Co-Founder of New to The Street. “This platform brings high-growth ETFs into the spotlight and makes their story accessible to millions of viewers.”

MUSQ ETF: Investing in the Sound Economy

The debut episode features MUSQ (NYSE:MUSQ), a thematic ETF providing diversified exposure to the $400B+ global music economy-spanning streaming platforms, audio technology, entertainment conglomerates, and digital content ecosystems. Key holdings include Spotify, Universal Music Group, Dolby Labs, and Tencent Music.

As part of the launch, MUSQ will be featured in:

• Long-form interviews airing on Fox Business and Bloomberg Television (as sponsored programming)

• 30-second commercials airing nationally during market hours

• Iconic billboard placement in Times Square and the NYC Financial District

• YouTube syndication to 2.5M+ subscribers and daily amplification across New to The Street’s social media audience of 700K+

“We’re excited to bring the MUSQ story to a global investment audience,” said a representative from MUSQ ETF. “This campaign showcases not only our fund’s innovation-but its cultural resonance.”

About ETF Leaders: Opportunities To Consider™

Created to spotlight innovation in ETFs, the series will feature fund managers and sponsors across sectors such as AI, blockchain, healthcare, energy, and next-gen consumer trends. Each segment delivers long-form editorial exposure, TV commercial support, and national digital-out-of-home reach through New to The Street’s media network.

“This is the next level of ETF storytelling-on the exchanges, on the air, and on the streets,” said Stephen Simon, President of New to The Street. “We’re thrilled to bring these funds to life in a way that’s never been done before.”

About New to The Street

Founded in 2009, New to The Street is a leading financial media platform producing televised interviews, sponsored programming, and investor engagement campaigns. With weekly broadcasts on Fox Business and Bloomberg Television (as sponsored programming), a rapidly growing YouTube channel, and one of the largest financial billboard networks in NYC, NTTS connects public and private companies with a wide-reaching audience of investors, analysts, and decision-makers.

To learn more or inquire about being featured on ETF Leaders: Opportunities To Consider™, please contact Monica@NewtoTheStreet.com or visit www.NewToTheStreet.com.

SOURCE: New To The Street

View the original press release on ACCESS Newswire